Health Sciences Center, Room 292
1000 E. University Ave., Dept. 3375
Laramie, WY 82071
Phone: (307) 766-6120
Fax: (307) 766-2953
email@example.com • (970) 495-8877Best Mode of Communication: E-mail
Office Hours: 8:30-4:30
Dr. Hilaire received her Doctor of Pharmacy degree from Duquesne University. She then completed a community pharmacy residency at the University of Toledo and a primary care specialty residency at the University of Tennessee. Dr. Hilaire's practice site is the Fort Collins Family Medicine Residency Program in Fort Collins, Colorado. Her clinical and research interest areas include diabetes, women's health, anticoagulation, and cardiovascular risk reduction. She is a certified diabetes educator (CDE) and a Board Certified Pharmacotherapy Specialist (BCPS). Dr. Hilaire coordinates and teaches Physical Assessment, as well as team teaching in the Therapeutics Series. She offers both Ambulatory Care and Pre-Residency Rotations. Dr. Hilaire is also the Ambulatory Care Preceptor for the PGY1 Pharmacy Practice Residency at Poudre Valley Hospital.
2012 UW College of Health Sciences Meritorious Service Award
2012 School of Pharmacy Phi Lambda Sigma Leadership Award
Diabetes, Hyperlipidemia, Anticoagulation
Therapeutics Series, Physical Assessment, Pharmacokinetics, Pharmacy Practice Lab, Ambulatory Care, Pre-Residency and Academic Rotations
REFEREED JOURNAL ARTICLES
Hilaire ML, Hornecker JR, Conjunctivitis Chapter 69 in: Katz MD, Matthias KR, Chisholm-Burns MA, Pharmacotherapy Principles & Practice Study Guide: A case based care plan approach, 3rd edition, New York NY: McGraw-Hill, 2013.
Hunter ML, Hilaire ML. Ophthalmic disorders. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, DiPiro JT, eds. Pharmacotherapy Principles and Practice. 3rd ed. New York; McGraw-Hill Companies, Inc.: 2013. p. 1093-1108.
Weiland CM, Hilaire ML. Bromocriptine Mesylate (Cycloset) for Diabetes Mellitus Type 2. American Family Physician. 2013;87(10):718-720.
Anne H. Metzger, Yolanda M. Hardy, Courtney Jarvis, Steven C. Stoner, Matthew Pitlick, Michelle L. Hilaire, Scott Hanes, Jack Burke, and Nicole M. Lodise. Essential Elements for a Pharmacy Practice Mentoring Program. American Journal of Pharmaceutical Education: 2013;77(2)Article 23.
Hilaire ML, Woods TM. Type 2 Diabetes: A focus on new guidelines. Formulary. 2013;48:55–67.
DeBittner MR, Adams A, Burns A, Ha C, Hilaire ML. et al. Effective Partnerships to Implement Pharmacists’ Services in Team-Based, Patient-Centered Care. A report of the 2010-2011 Professional Affairs Committee. American Journal of Pharmaceutical Education 2011;75(10):S11.
Woods TM, Hilaire ML. Opioid abuse and dependence: Treatment review and future options. Formulary. 2010;45:284–291.
Hilaire ML, Wozniak JR. Xopenex HFA for treatment of bronchospasm. American Family Physician 2007;75(2):246-48.
Hilaire ML. Treatment of Osteoarthritis. U.S. Pharmacist 2006 May;31(5):49-55.
Self T, Cross LB, Nolan S, Weibel J, Hilaire M, Franks AS, Finch C, Tolley E. Gender Differences in the Use of Peak Flow Meters and Their Effect on Peak Expiratory Flow. Pharmacotherapy. 2005;25(4):526-30
Hilaire ML. An Update on Eating Disorders. U.S. Pharmacist 2005 Sept; 30 (9): HS35-HS38.
Hilaire ML, Cross LB, Eichner SF. Treatment of Migraine Headaches with Sumatriptan in Pregnancy. Ann Pharmacother 2004;38:1726-30.
Grande KJ, Hilaire ML. Counseling on complications of diabetes. U.S. Pharmacist 2004 Nov; 29 (11):81-92.
Hilaire ML, Powers M, Kitz M. Training Pharmacy Technicians In Community Pharmacy About Technical Aspects Of Blood Glucose Meters. J Pharmacy Technol, 2004;20:178-82.